SONO - SONO

에 대한 최신 뉴스 Sonos (NASDAQ:SONO) 주식

Sonos

Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa and the Asia Pacific. Generating a majority of its revenue from the Americas.

Earnings

News

After-Hours Center

Movers

SONO

소노스(NASDAQ:SONO)는 수요일(13일) 장 마감 후 4분기 실적을 발표했다. 이번 분기 실적 주요 수치는 다음과 같다.실적 세부 내용: 소노스의 GAAP 분기 주당순손실은 44센트로 애널리스트 컨센서스 예상치 주당순손실 38센트에 미치지 못했다. 분기 매출은 2억 5,540만 달러로 애널리스트 컨센서스 예상치 2억 4,949만 달러를 상회했다. 소노스의 분기 GAAP 매출총이익률은 40.3%를 기록했다.

소노스, 엇갈린 4분기 실적 발표 후 시간외 거래 5% 상승

Sonos Inc

SONO GROUP N V by Sono Group N.V.

Sono Group NV

Sono-Tek Corp

Sonoco Products Co

Sonocom Co Ltd

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals Inc

SONOMAX TECHNOLOGIES INC by Sonomax Technologies Inc

Sonomax Technologies Inc

Sonoran Desert Copper Corp

SONORAN DESERT COPPER CP by SONORAN DESERT COPPER CORP

Sonoro Energy Ltd

Sonoro Gold Corp

SONOVA HOLDING AG ORD by Sonova Holding AG

Sonova Holding AG

SONOVA HLDNG AG UNSP/ADR by Sonova Holding AG

Sonovia Ltd

UBS analyst Batya Levi maintains Warner Music Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) with a Buy and lowers the price target from $43 to $41.

Price Target

Analyst Ratings

UBS Maintains Buy on Warner Music Gr, Lowers Price Target to $41

Roth MKM analyst Boobalan Pachaiyappan initiates coverage on Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) with a Buy rating and announces Price Target of $68.

Initiation

VRNA

Roth MKM Initiates Coverage On Verona Pharma with Buy Rating, Announces Price Target of $68

VRTX

Vertex And Zai Lab Announce Strategic Agreement To Develop And Commercialize Povetacicept In Mainland China, Hong Kong Sar, Macau Sar, Taiwan Region And Singapore

Needham analyst Mayank Tandon maintains Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) with a Buy and raises the price target from $36 to $43.

DAVA

Needham Maintains Buy on Endava, Raises Price Target to $43

ABSI

Absci Corporation And Owkin Announced A Partnership Bringing Together Two Leading Ai Platforms To Rapidly Discover And Design Novel Therapeutics For Patients

Health Care

Financing

Offerings

General

CMPS

Compass Pathways Has Priced Its Underwritten Offering Of 24.01M American Depositary Shares To Certain Institutional Investors, Pre-funded Warrants To Purchase Up To 11.04M ADSs, At $4.275 Per ADS And Accompanying ADS Warrant, And $4.2649 Per Pre-funded Warrant And Accompanying ADS Warrant

Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) reported quarterly adjusted earnings of $3.25 per share which missed the analyst consensus estimate of $3.31 by 1.81 percent. This is a 1.88 percent increase over earnings of $3.19 per share from the same period last year. The company reported quarterly sales of $2.46 billion which missed the analyst consensus estimate of $2.53 billion by 2.61 percent. This is a 0.28 percent decrease over sales of $2.47 billion the same period last year.

Earnings Misses

Constellation Brands Q3 Adj $3.25 Misses $3.31 Estimate, Sales $2.46B Miss $2.53B Estimate

Needham analyst Joshua Reilly reiterates Verint Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNT#NASDAQ">VRNT</a>) with a Buy and maintains $40 price target.

Reiteration

VRNT

Needham Reiterates Buy on Verint Systems, Maintains $40 Price Target

UBS analyst Manav Gupta initiates coverage on Tyson Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) with a Neutral rating and announces Price Target of $62.

UBS Initiates Coverage On Tyson Foods with Neutral Rating, Announces Price Target of $62

DAL: 6% &#x7C; <a href="https://www.benzinga.com//node/42908316">Delta Air Lines Q4 2024 Adj. EPS $1.85 Beats $1.76 Estimate, Sales $14.437B Beat $14.212B Estimate</a>
&nbsp;
CEG: 10 &#x7C; <a href="https://www.benzinga.com//node/42908788">Constellation And Calpine Corp. Inks Pact Under Which Constellation Will Acquire Calpine In A Cash And Stock Transaction Valued At An Equity Purchase Price Of Approximately $16.4B</a>
&nbsp;
VMAR: 136% &#x7C; <a href="https://www.benzinga.com//node/42905522">Vision Marine Partners with Calip Group to Produce Advanced Cooling Plates for Electric Boat Batteries</a>

Trading Ideas

VMAR

Market-Moving News for January 10th

ZENA

ZenaTech's ZenaDrone Multipurpose AI Drone Applies For FAA Part 137 Crop Sprayer Certification For Agricultural And Wildfire Industry Use

Roth MKM analyst Boobalan Pachaiyappan initiates coverage on Cingulate (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CING#NASDAQ">CING</a>) with a Buy rating and announces Price Target of $12.

CING

Roth MKM Initiates Coverage On Cingulate with Buy Rating, Announces Price Target of $12

Cost savings from the Germany Restructuring are expected to be largely reinvested across the Company's core initiatives and remaining international markets over the balance of 2025.

Wayfair Estimates Aggregate Charges Of $102M - $111M Due To Germany Restructuring

Chinese EV startup Nio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) launched its new affordable EV brand Onvo in May. The brand started selling its first vehicle &#8211; the Onvo L60 &#8211; in late September and since then, Nio sales have been on the rise.
What Happened:&nbsp;The Onvo L60 is a mid-size electric SUV that starts at 206,900 yuan ($28,347) with the battery pack included, much lower than Tesla's affordable models Model 3 or Model Y in China.
Onvo Sales Trajectory: In September, Nio delivered 832 Onvo L60s despite having only a few selling days. In October, the first full month of sales, Onvo deliveries rose to 4,319. In November, deliveries rose to 5,082, implying rising demand for the vehicle.
In August, the month before Onvo deliveries commenced, Nio delivered 20,176 vehicles, marking a growth of just 4.4% year-on-year.
In September, the first month of Onvo L60 deliveries, Nio's total deliveries jumped 35.4% as compared to the corresponding period last year. In October and November, deliveries&nbsp;<a href="https://www.benzinga.com/24/12/42260165/li-auto-xpeng-nio-heres-how-november-deliveries-of-chinese-ev-startups-stack-up" target="_blank" rel="noreferrer noopener">marked an increase of 30.5% and 29%</a>, respectively.
Why It Matters: In the last month of 2024, Nio delivered over 10,000 Onvo brand vehicles and about 21,000 Nio brand vehicles, marking a <a href="https://www.benzinga.com/25/01/42758540/us-listed-chinese-ev-startups-clock-delivery-growth-in-december-li-auto-tops-the-chart-mona-m03-spurs-xpeng-nios-onvo-breaches-10000-monthly-delivery-milestone">whopping 72.9% rise from its sales in December 2023. </a>
Nio marked over 20,000 cumulative deliveries in just a hundred days of launch.
Nio identifies itself as a premium EV brand. Its ET9, for instance, starts at 788,000 yuan, including the battery.
The low-cost EV from the company's Onvo brand has helped Nio move to the low-cost EV segment, boosting demand in the competitive EV space in China.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Month</td>
<td>Onvo Brand Sales</td>
<td>Nio Overall Sales</td>
<td>Nio&#8217;s YoY Sales Growth</td>
</tr>
<tr>
<td>August</td>
<td>&#8211;</td>
<td>20,176</td>
<td>4.4%</td>
</tr>
<tr>
<td>September</td>
<td>832</td>
<td>21,181</td>
<td>35.4%</td>
</tr>
<tr>
<td>October</td>
<td>4,319</td>
<td>20,976</td>
<td>30.5%</td>
</tr>
<tr>
<td>November</td>
<td>5,082</td>
<td>20,575</td>
<td>29%</td>
</tr>
<tr>
<td>December</td>
<td>10,528</td>
<td>31,138</td>
<td>72.9%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Source: Nio</figcaption></figure>
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/42905406/tesla-launches-refreshed-model-y-in-china-amid-rising-competition" target="_blank" rel="noreferrer noopener">Tesla Launches Refreshed Model Y In China Amid Rising Competition</a></li>
</ul>
Photo courtesy: Nio

Tech

Onvo L60 Delivers Big For Nio: Over 20,000 Vehicles Sold In First 100 Days

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) with a Buy and maintains $100 price target.

MLTX

HC Wainwright & Co. Reiterates Buy on MoonLake, Maintains $100 Price Target

<ul>
<li>Vepdegestrant to be combined with Pfizer's novel investigational CDK4 inhibitor atirmociclib in a first-line Phase 3 trial planned to initiate in 2025; a second-line Phase 3 combination trial will combine vepdegestrant with a CDK4/6 inhibitor, also planned to initiate in 2025.</li>
<li>Topline data from the monotherapy Phase 3 VERITAC-2 trial of vepdegestrant anticipated in 1Q25.</li>
<li>The Company recently initiated a Phase 1 trial with PROTAC LRRK2 degrader ARV-102 in patients with Parkinson's disease.</li>
<li>Data disclosures anticipated from multiple clinical and pre-clinical programs, including ARV-102 and ARV-393, and planned IND submission for a PROTAC KRAS G12D degrader in 2025</li>
</ul>

Biotech

ARVN

Arvinas Announced Updated Guidance For The Planned First- And Second-line Combination Trials For Vepdegestrant For Locally Advanced Or Metastatic Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer

BCRX

BioCryst Says ORLADEYO Net Revenue Expected Between $515M-$535M In 2025, Total revenue (Including RAPIVAB) Will Be $540M-$560M

UBS analyst Curt Woodworth upgrades Commercial Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMC#NYSE">CMC</a>) from Sell to Neutral and lowers the price target from $56 to $54.

Upgrades

UBS Upgrades Commercial Metals to Neutral, Lowers Price Target to $54

Wayfair Reveals Decision To Exit The German Market, Effective Immediately; Expects Workforce Restructuring Impacting Approximately 730 Employees - Filing

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) with a Buy and maintains $15 price target.

HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

Sonos, Inc. 2024 Q4 - Results - Earnings Call Presentation

Sonos, Inc. (SONO) Q4 2024 Earnings Call Transcript

Sees Q1 adjusted EBITDA $35M-$79M. Sees Q1 GAAP gross margin 41%-43%. Guidance taken from Q4 earnings conference call. Published first on TheFly – ...

Sonos sees Q1 revenue $480M-$560M, consensus $518.95M

Craig-Hallum analyst Alex Fuhrman raised the firm's price target on Sonos (SONO) to $15 from $10 and keeps a Hold rating on the shares. The firm no...

Sonos price target raised to $15 from $10 at Craig-Hallum

Audio manufacturer Sonos Inc. ($SONO) posted mixed results for Q4 2024. The company has experienced a challenging environment owing to an unprecede...

Sonos' (SONO) Rebounding from Mobile App Debacle

Sonos Inc (SONO) has disclosed a new risk, in the Demand category. Sonos Inc. is facing significant challenges following the launch of its redesign...

Sonos Faces Financial Strain Amid App Rollout Challenges

Trade Desk working on TV OS 'Ventura,' CEO says efforts won't compete with Roku - report

Catalyst Watch: Robotaxi IPO, OPEC+, holiday shopping data, and movie blockbusters

Sonos: This Turnaround Will Take Awhile (Rating Downgrade)

American Century Small Cap Growth Fund Q3 2024 Commentary

ADMA

AMZN

AVDX

AZEK

BBWI

BOOT

CGJTF

CMCSA

CRWD

CWST

DELL

ENVX

ETSY

FBIN

GOOG

GOOGL

HEAR

HNST

IBRX

ITGR

JNPR

MSTR

NTGR

NTRA

OLLI

PARA

PENN

PONY

QTWO

REGN

ROKU

SITE

SPOT

TRUE

TTGT

VSTO

WDAY

XPRO

ZNOG

Press Releases

Sonos Announces Participation in Maxim Group Virtual Tech Conference

Sonos Announces Date for Third Quarter Fiscal 2024 Financial Results and Conference Call

Sonos Reports Third Quarter Fiscal 2024 Results

Sonos and Sporty & Rich Serve Up Tenniscore Style with New Limited Edition Headphones

Sonos Announces New Quality and Customer Experience Commitments

Sonos Reveals Arc Ultra, its New Soundbar Featuring Sound Motion™

Sonos Announces Date for Fourth Quarter and Fiscal 2024 Financial Results and Conference Call

Sonos Reports Fourth Quarter and Fiscal 2024 Results

Sonos to Launch Era 100 Pro, Its First-Ever Solution for Professional Installation, in January 2025

Sonos Reports Environmental Progress On Headphones, New Products, and Climate Plan

Emerson Radio

Algorhythm Holdings

Sony Group Corporation American Depositary Shares

Sony Gr

Universal Electronics Inc. - Common Stock

Universal Electronics

VOXX International Corporation - Class A Common Stock

VOXX International

Morgan Stanley

Rosenblatt

B of A Securities

Craig-Hallum

DA Davidson

소노스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONO#NASDAQ">SONO</a>)는 수요일(13일) 시장 마감 후 4분기 실적을 발표했다. 이번 <a href="https://www.benzinga.com/pressreleases/24/11/b41953920/sonos-reports-fourth-quarter-and-fiscal-2024-results" target="_blank" rel="noopener">분기 실적</a> 주요 수치는 다음과 같다.
실적 세부 내용: 소노스의 GAAP 분기 주당순손실은 44센트로 애널리스트 컨센서스 예상치 주당순손실 38센트에 미치지 못했다. 분기 매출은 2억 5,540만 달러로 애널리스트 컨센서스 예상치 2억 4,949만 달러를 상회했다. 소노스의 분기 GAAP 매출총이익률은 40.3%를 기록했다.
그리고 2024회계연도 GAAP 주당순손실은 31센트로 애널리스트 컨센서스 예상치 주당순손실 27센트를 하회했다. 회계연도 매출은  15억 1,800만 달러로 애널리스트 컨센서스 예상치 15억 1,300만 달러를 상회했다. 회계연도 GAAP 매출총이익률은 45.4%로 보고되었다.
더 읽기: <a href="https://kr.benzinga.com/news/usa/stocks/%EB%8F%85%EC%A0%90-%EC%9B%8C%ED%81%AC%EC%8A%A4%ED%8F%AC%ED%8A%B8%EC%9D%98-3%EB%B6%84%EA%B8%B0-%EB%A7%A4%EC%B6%9C%EC%9D%B4-581-%EA%B8%89%EC%A6%9D-%EC%8B%A0%EC%A0%9C%ED%92%88-%EB%9D%BC%EC%9D%B8/" target="_blank" rel="noopener">독점: 워크스포트의 3분기 매출이 581% 급증, 신제품 라인이 성장 촉진, 2025년 전망 상향</a>
패트릭 스펜스(Patrick Spence) 소노스 CEO는 &#8220;우리 팀이 앱 복구에 올인한 덕분에 소프트웨어 품질을 모두가 자랑스러워할 만한 수준으로 끌어올리는 데 상당한 진전을 이루었고, 그 덕분에 기대했던 신제품인 Arc Ultra와 Sub 4를 연휴에 맞춰 출시할 수 있었다&#8221;고 하면서 다음과 같이 덧붙였다.
"신제품에 대한 초기 피드백은 매우 긍정적이었으며, 올해 초에 출시한 에이스와 함께 역대 최강의 제품 라인업을 갖추게 되었다. 소노스는 여전히 최고의 홈 오디오 시스템이며, 업계 최고의 제품 라인업을 통해 더 많은 고객을 확보하고 충성도 높은 고객층을 공고히 하는 데 주력하고 있다.&#8221;
소노스 주가 움직임: <a href="//pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw"" target="_blank" rel="noopener">벤징가 프로</a>에 따르면 소노스 주가는 5.82% 상승한 14.90달러에 거래되고 있다.
사진 출처: Shutterstock의 Niks Evalds
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스 기사를 이용하면 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Sonos

뉴스

에 대한 최신 뉴스 Sonos (NASDAQ:SONO) 주식

목요일, 11월 14, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌